Abstract:
OBJECTIVE To investigate the effects of L-mimosine on the proliferation and apoptosis of melanoma cells and its molecular mechanisms.
METHODS The effects of different concentrations of L-mimosine on the viability of melanoma A375 and B16 cells were examined by the MTT assay.The ability of L-Mimosine to affect colony formation was assessed by the plate colony formation assay.The effects of L-mimosine on cell apoptosis, reactive oxygen species(ROS), and mitochondrial membrane potential were analyzed by flow cytometry.The changes in the expression levels of intracellular proteins such as Bcl-2, Bax, Cyt C, Cleaved Caspase-3, Cleaved Caspase-9, Bim-EL, Bad, p-JNK, p-c-Jun, p-MKK4, and p-ASK1 were detected by Western blot. The tumor-bearing mouse model was subjected to histological and TUNEL staining analysis of tumor tissues after treatment with normal saline, L-mimosine alone, and L-mimosine in combination with N-acetylcysteine (NAC).
RESULTS L-mimosine significantly inhibited the proliferation of A375 and B16 cells and significantly promoted cell apoptosis. Western blot analysis showed that L-mimosine could significantly increase the content of Apaf-1 and Cyt C in the cytoplasm, up-regulate the expression of Cleaved PARP, Cleaved Caspase-3, Cleaved Caspase-9, Bax, Bim-EL and Bad, and down-regulate the expression of anti-apoptotic protein Bcl-2. Further experiments showed that L-mimosine significantly induced the accumulation of ROS in A375 cells and activated the JNK/c-Jun signaling pathway, which was manifested by the significant increase of p-JNK, p-c-Jun, p-MKK4 and p-ASK1. Additionally, the antioxidant NAC could significantly antagonize the ROS accumulation induced by L-mimosine, thereby reversing the pro-apoptotic effects of L-mimosine on melanoma cells. In vivo experiments, NAC also significantly antagonized the tumor growth inhibition induced by L-mimosine, as evidenced by increased tumor volume and reversed expression levels of apoptosis-related proteins.
CONCLUSION L-mimosine induces apoptosis in melanoma cells by increasing ROS levels and activating the JNK/c-Jun signaling pathway.